BCTXZ News and Press, BriaCell Therapeutics Corp. Warrant From 01/14/26

A look at the top 10 most actives in the United States Inspire Veterinary Partners Inc. (IVP) rose 203.9% to $0.0699 on volume of 2,293,532,079 shares Oriental Culture Holding LTD (OCG) fell 3.5% to $0.0109 on volume of 908,000,323 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) r...

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer ca...

[IMAGES BELOW] 11-month sustained complete resolution of lung metastasis observed in Bria-OTS Phase 1/2a metastatic breast cancer study. No treatment limiting toxicities reported. Patient maintained stable disease at all other evaluable sites. PHILADELPHIA and VANCOUVER, British...

A look at the top 10 most actives in the United States Aspire Biopharma Holdings Inc. (ASBP) rose 25.7% to $0.132 on volume of 489,285,248 shares Oriental Culture Holding LTD (OCG) fell 2.7% to $0.0216 on volume of 336,903,531 shares Hyperscale Data Inc. (GPUS) rose 44.5% to $0.3703 on volu...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 12.9% to $2.725 on volume of 428,993,730 shares Datavault AI Inc. (DVLT) rose 70.5% to $1.1119 on volume of 283,743,172 shares Hyperscale Data Inc. (GPUS) rose 56.3% to $0.287 on v...

A look at the top 10 most actives in the United States PicoCELA Inc. (PCLA) rose 187.7% to $0.35415 on volume of 767,352,903 shares Vivakor Inc. (VIVK) rose 38.2% to $0.085 on volume of 419,300,053 shares Trinity Biotech plc (TRIB) rose 55.9% to $1.3902 on volume of 168,746,679 shares Dir...

Nature Medicine asked leading researchers to name their top clinical trial for 2026, from long-awaited vaccines for infectious diseases to new treatments for advanced cancers and long COVID BriaCell’s Phase 3 clinical trial in metastatic breast cancer featured as “clinical tria...

BriaCell presents positive clinical data in three posters at the San Antonio Breast Cancer Symposium (SABCS ® ) Phase 3 study of Bria-IMT™ plus immune check point inhibitor (CPI) continues to support biomarkers to identify patients who benefit from treatment with BriaC...

Over 230 patients screened and over 160 patients enrolled in BriaCell’s pivotal Phase 3 study in metastatic breast cancer (MBC) Enrollment exceeding expectations with strong clinical site and patient interest Topline interim data readout expected in 1H2026 ...

Three poster presentations at the San Antonio Breast Cancer Symposium (SABCS), now available and to be presented on December 10, 2025, highlight robust survival and clinical benefit data in Phase 2, plus positive key biomarker data from the pivotal Phase 3 The pivotal Phase 3 study of...